非酒精性脂肪性肝病与结直肠肿瘤风险
在26 540名接受同日首次结肠镜和腹部超声的无症状成人中,非酒精性脂肪性肝病(NAFLD)患者任何结直肠肿瘤(38.0% vs. 28.9%)和进展期结直肠肿瘤(2.8% vs. 1.9%)的患病率均高于无NAFLD者。多变量模型中,NAFLD与任何结直肠肿瘤的OR为1.10(95%CI:1.03-1.17),与进展期结直肠肿瘤的OR为1.21(95%CI:0.99-1.47)。NAFLD的存在和严重程度与任何结直肠肿瘤及进展期结直肠肿瘤密切相关。
要点
- NAFLD患者任何结直肠肿瘤患病率为38.0%,高于无NAFLD者的28.9%。
- NAFLD患者进展期结直肠肿瘤患病率为2.8%,高于无NAFLD者的1.9%。
- 严重肝病者的任何或进展期结直肠肿瘤风险高于轻度肝病者。
核心结论
- NAFLD的存在和严重程度与任何结直肠肿瘤及进展期结直肠肿瘤密切相关,提示临床医生应意识到NAFLD患者结直肠肿瘤风险增加。
研究设计与样本
- 共分析26 540名接受健康体检、同日首次结肠镜和腹部超声的无症状成人;NAFLD由超声诊断。
主要发现
- NAFLD患者任何结直肠肿瘤患病率为38.0%,无NAFLD者为28.9%。
- NAFLD患者进展期结直肠肿瘤患病率为2.8%,无NAFLD者为1.9%。
- 调整年龄、性别、吸烟、酒精、体重指数、结直肠癌一级亲属家族史、阿司匹林使用和代谢因素后,NAFLD对比无NAFLD者任何结直肠肿瘤的OR为1.10(95%CI:1.03-1.17),进展期结直肠肿瘤的OR为1.21(95%CI:0.99-1.47)。
- 按肝病严重程度的无创参数分层,严重肝病者任何结直肠肿瘤或进展期结直肠肿瘤风险高于轻度肝病者。
关键数值与推荐
- 进展期结直肠肿瘤定义为浸润性癌或直径至少10 mm、伴高级别上皮内瘤变、绒毛状组织学特征或任意组合的腺瘤。
- NAFLD由腹部超声诊断。
临床怎么用
- 原文结论提示临床医生应意识到NAFLD患者结直肠肿瘤风险增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is associated with colorectal neoplasia. Yet, NAFLD ranges from simple steatosis to steatohepatitis with advanced fibrosis. AIM: To investigate the risk of colorectal neoplasia according to the presence and severity of NAFLD. METHODS: A total of 26 540 asymptomatic adults who underwent same day first-time colonoscopy and abdominal ultrasonography as a health check-up programme were analysed. NAFLD was diagnosed by ultrasonography. Advanced colorectal neoplasia was defined as an invasive cancer or adenoma that was at least 10 mm in diameter, had high-grade dysplasia, or had villous histological characteristics or any combination thereof. RESULTS: NAFLD patients had a higher prevalence of any colorectal neoplasia (38.0% vs. 28.9%) and advanced colorectal neoplasia (2.8% vs. 1.9%) compared to those without NAFLD. In a multivariable model adjusted for age, sex, smoking, alcohol, body mass index, first-degree family history of colorectal cancer, aspirin use and metabolic factors, the odd ratios comparing patients with NAFLD to those without were 1.10 [95% confidence interval (CI): 1.03-1.17] for any colorectal neoplasia and 1.21 (95% CI: 0.99-1.47) for advanced colorectal neoplasia. When NAFLD patients were further stratified according to the non-invasive parameters of liver disease severity, the risk of any colorectal neoplasia or advanced colorectal neoplasia was higher for those with severe liver diseases than those with mild liver diseases. CONCLUSIONS: The presence and severity of NAFLD were closely associated with any colorectal neoplasia and advanced colorectal neoplasia, suggesting that clinicians should be aware of the increased risk of colorectal neoplasia in patients with NAFLD.
引用
- Ahn JS, Sinn DH, Min YW, et al. Non-alcoholic fatty liver diseases and risk of colorectal neoplasia. Aliment Pharmacol Ther. 2016. PMID: 27859470. doi:10.1111/apt.13866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。